Dissociative vs. Psychedelic
Ketamine is classified as a dissociative anesthetic, not a classical psychedelic. Unlike psilocybin or LSD, which act primarily on serotonin receptors, ketamine blocks NMDA glutamate receptors. This produces a unique set of effects: dissociation from body and environment, pain relief, and at higher doses, a profoundly altered state of consciousness known as a "K-hole." While it can produce psychedelic-like visionary states, its pharmacology and risk profile are fundamentally different.
Routes of Administration & Bioavailability
Route changes absorption, onset, duration, and medical risk. Published estimates vary by formulation and study design; they are not safe conversion factors for self-dosing:
Sublingual / Oral
Variable and formulation-dependent
Compounded products are sometimes prescribed off-label. They are not FDA-approved for psychiatric indications and do not have the same evidence or REMS safeguards as Spravato.
Intranasal
Absorption can be unpredictable
Spravato is a specific FDA-approved esketamine product used only under direct supervision in a certified healthcare setting. Illicit powders and compounded sprays are not equivalent to Spravato.
Intramuscular (IM)
Rapid medical route
Used in selected clinical settings. Once injected, delivery cannot be slowed or stopped the way an IV infusion can, making medical screening and observation important.
Intravenous (IV)
Direct bloodstream delivery
Clinical or hospital route with precise delivery and monitoring. A commonly studied off-label psychiatric approach uses racemic ketamine by infusion; this is not the Spravato protocol.
Recognizing Escalating Risk
No universal amount reliably predicts an effect. Product identity, concentration, route, other drugs, health conditions, and individual response all matter. A dose that previously felt manageable can still cause an emergency. Use these signs to recognize danger—not to target an experience.
Early impairment
Effects may begin before they feel obvious
Judgment, balance, reaction time, and pain awareness may be impaired even when someone feels functional. Driving, swimming, heights, traffic, cooking, and machinery are unsafe.
Significant dissociation
Mobility and communication can deteriorate quickly
Confusion, slurred speech, inability to walk safely, panic, vomiting, or reduced awareness can occur. A sober companion cannot provide the monitoring or emergency treatment available in a clinic.
Severe impairment
Loss of protective responses can become life-threatening
Someone may be unable to speak, move, protect their airway, or respond normally. Vomiting while heavily sedated can lead to aspiration. Breathing risk is higher with alcohol, opioids, benzodiazepines, GHB, sleep medicines, or other sedatives.
Medical emergency signs
Call 911—do not wait for the effects to pass
Call 911 for slow, irregular, or stopped breathing; blue or gray lips; inability to wake the person; seizure; collapse; severe chest pain; suspected aspiration; dangerous agitation; or serious injury. Place an unconscious breathing person on their side and follow dispatcher instructions.
What is a K-Hole?
"K-hole" is informal language for profound dissociation. It is not a defined safe target or clinical endpoint. A person may be unable to move, communicate, recognize danger, or protect their airway. Apparent deep dissociation can be difficult to distinguish from poisoning or another medical emergency. Do not assume an unresponsive person will simply recover without help.
Clinical Use: Spravato & IV Infusions
Ketamine has gained significant attention as a treatment for treatment-resistant depression. These are distinct treatments and should not be described interchangeably:
- Spravato (esketamine) — An FDA-approved nasal spray with label-specific fixed doses and indications. It must be administered under direct supervision in a REMS-certified healthcare setting, with monitoring for at least two hours.
- IV racemic ketamine — FDA-approved as an anesthetic and used off-label by some clinicians for depression or pain. Psychiatric research protocols vary; actual treatment must be prescribed, individualized, and medically monitored.
- Compounded ketamine — Oral, sublingual, or nasal compounded products are not FDA-approved for psychiatric indications and do not use the Spravato REMS process.
The Spravato label warns about sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Blood pressure and clinical status must be assessed. Patients should not drive until the next day after a restful sleep, following their clinician's instructions.
Why Timing Is Unpredictable
Effects can continue or return after someone believes the peak has passed. Route, formulation, food, metabolism, other drugs, and redosing all change timing. Do not drive, swim, supervise children, or perform safety-sensitive tasks until fully recovered. Spravato patients must follow the label's next-day driving restriction and their clinician's discharge instructions.
Serious Health Risks
- Bladder Damage — Chronic, frequent use (especially daily or near-daily) can cause severe bladder damage (ketamine cystitis). Symptoms include painful urination, urgency, frequency, and in extreme cases, bladder removal. This is one of the most significant long-term risks and is dose- and frequency-dependent.
- Addiction Potential — Unlike classical psychedelics, ketamine has real addiction potential. Tolerance develops rapidly, and psychological dependence can occur. The dissociative "escape" quality makes it particularly habit-forming for some individuals.
- Respiratory Depression — At high doses, especially combined with other depressants (alcohol, benzodiazepines, opioids, GHB, or sleep medicines), ketamine can dangerously suppress breathing. An unresponsive person or abnormal breathing requires emergency help.
- Aspiration Risk — Nausea and vomiting can occur. In a dissociated state, aspiration (inhaling vomit) is a serious risk. Put an unconscious breathing person in the recovery position, call 911, and follow dispatcher instructions. Do not give food, drink, or medication.
Tolerance & Frequency
Tolerance to ketamine develops rapidly with regular use. Users who dose frequently find they need significantly more to achieve the same effects, which dramatically increases the risk of bladder damage and addiction.
There is no evidence-based universal "reset" period or safe maximum frequency for nonmedical use. Escalating amount or frequency, craving, unsuccessful efforts to stop, or continued use despite urinary, relationship, school, or work problems are reasons to seek professional help. Clinical schedules are diagnosis- and product-specific and should not be copied for self-treatment.
Safety Recommendations
- 1.Choose supervised medical care — A sober companion is not a substitute for screening, monitoring, oxygen, suction, or emergency treatment
- 2.Do not convert between routes — Absorption differs and simple dose conversions can cause overdose
- 3.Never mix with depressants — No alcohol, benzodiazepines, opioids, or GHB
- 4.Stay in one place — Impaired coordination makes falls and injuries common
- 5.Follow clinical fasting instructions — Requirements vary by treatment and health history; do not invent your own rule
- 6.Unknown products remain dangerous — Appearance and a single reagent result cannot establish identity, potency, purity, or safety
- 7.Monitor urinary health — If you notice any bladder symptoms, stop immediately and see a doctor
Who Should NOT Use Ketamine
A clinician should review medical history, medications, pregnancy status, substance-use risk, and mental health before treatment. Spravato has specific contraindications and warnings. Important concerns include:
- Conditions in which an increase in blood pressure or intracranial pressure poses a serious risk
- Aneurysmal vascular disease, arteriovenous malformation, or prior intracerebral hemorrhage for Spravato
- Cardiovascular, respiratory, liver, bladder, or urinary disease
- Current or prior substance-use disorder
- Psychosis, mania, severe agitation, or other unstable psychiatric symptoms
- Pregnancy, plans for pregnancy, or breastfeeding
- Sedatives, opioids, stimulants, MAOIs, and other prescription, over-the-counter, or recreational drugs
If you are taking any medications, consult a healthcare provider to check for potential interactions before making any decisions.
Emergency and crisis help
Call 911 for abnormal breathing, blue or gray lips, inability to wake someone, seizure, collapse, severe chest pain, suspected aspiration, dangerous agitation, or serious injury. Stay with the person and follow dispatcher instructions.
In the U.S., Poison Control is 1-800-222-1222. Call or text 988 for suicidal thoughts or a mental-health crisis. Call 911 when there is immediate physical danger.
Authoritative Sources
Our Recommendation
If you are interested in ketamine for mental health purposes, seek a licensed clinical provider offering supervised ketamine-assisted therapy or Spravato treatment. Clinical settings provide medical screening, proper dosing, monitoring, and integration support. Self-administration carries significantly higher risks including addiction, bladder damage, and dangerous interactions. Education is the first step toward safer choices.
Continue Learning
Read What Is Ketamine?, Drug Interactions & Contraindications, Crisis & Difficult Experiences, and Navigating Psychedelic Therapy.